drug

EG-501

Phase 2updated 3mo ago

by Shenzhen Evergreen Therapeutics Co Ltd

Phase 2

community read0 votes

indications

Lupus

all catalysts(0)

nothing on the calendar yet

Trials studying EG-501

phase2EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Studycompletedn=131

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 40m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

EG-501

Phase 2updated 3mo ago

by Shenzhen Evergreen Therapeutics Co Ltd

Phase 2

community read0 votes

indications

Lupus

all catalysts(0)

nothing on the calendar yet

Trials studying EG-501

phase2EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Studycompletedn=131

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 40m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

EG-501

indications

all catalysts(0)

Trials studying EG-501

News(0)

Report a data issue

comments(0)

EG-501

indications

all catalysts(0)

Trials studying EG-501

News(0)

Report a data issue

comments(0)